MétaCan
Menu
Back to cohort

Saccadic Behaviour in an Eye-Tracking Task is Differentially Altered by Neurodegenerative Diseases (2184)

2020· article· en· W3211052139 on OpenAlexaffabout
Heidi C. Riek, Brian C. Coe, Don Brien, Sandra E. Black, Michael Borrie, Dar Dowlatshahi, Elizabeth Finger, Morris Freedman, Donna Kwan, Anthony E. Lang, Connie Marras, Mario Masellis, Christen Shoesmith, Richard H. Swartz, Brian Tan, Maria Carmela Tartaglia, Lorne Zinman

Bibliographic record

VenueNeurology · 2020
Typearticle
Languageen
FieldComputer Science
TopicGaze Tracking and Assistive Technology
Canadian institutionsToronto Western HospitalBaycrest HospitalUniversity of OttawaSt Joseph's Health CareSunnybrook Health Science CentreHealth Sciences CentreLondon Health Sciences CentreQueen's University
Fundersnot available
KeywordsAntisaccade taskSaccadic maskingSaccadeEye movementFixation (population genetics)DementiaDiseaseNeurosciencePsychologyFrontotemporal dementiaMedicineCognitionAudiologyAbnormalityPeripheralPhysical medicine and rehabilitationInternal medicinePsychiatryPopulation

Abstract

fetched live from OpenAlex

Objective: Characterize saccadic behaviour across several neurodegenerative diseases to determine patterns of behavioural alterations that may be used as disease-specific biomarkers. Background: The overlap of oculomotor circuitry and brain regions affected by neurodegenerative disease suggests assessment of eye movements can differentiate and monitor such diseases. Typifying saccadic behavioural “fingerprints” found in neurodegenerative diseases, in combination with clinical measures, may enhance screening, diagnosis, and tracking of disease progression. Design/Methods: The Ontario Neurodegenerative Disease Research Initiative has collected data from individuals with one of six neurodegenerative diseases: Alzheimer’s disease (AD), mild cognitive impairment (MCI), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and vascular cognitive impairment (VCI). Patients (n=520, age 40–87) and a cohort of healthy age-matched controls (n=133, age 50–93) completed a randomly interleaved pro- and anti-saccade task while their eye movements were tracked with high-speed video. The colour of a central fixation point conveyed the instruction for a prosaccade (look at peripheral target) or antisaccade (look away from peripheral target). We assessed saccade parameters including task errors, reaction times, and their association with clinical parameters (e.g. MoCA score). Results: Patterns of abnormality differed across disease groups. Each group displayed abnormalities on a unique subset of task-related parameters – e.g., antisaccade reaction time significantly increased in PD and VCI relative to controls; antisaccade direction errors (erroneously looking at the peripheral target) at very short latencies significantly increased in FTD and PD; and fixation breaks (looking away from the fixation point) significantly increased in AD and VCI. A subset of performance parameters (fixation breaks, antisaccade direction errors) were progressively worsened between controls, MCI, and AD. Conclusions: Neurodegenerative diseases display unique oculomotor “fingerprints” that provide insight into disease-specific brain dysfunction. These fingerprints signify unique behavioural biomarkers for neurodegeneration that, in combination with clinical measures, can powerfully inform novel diagnostic tools and treatments. Disclosure: Dr. Riek has nothing to disclose. Dr. Coe has nothing to disclose. Dr. Brien has nothing to disclose. Dr. Black has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Hoffman La Roche. Dr. Black has received research support from Genentech, Roche, Biogen, GE Healthcare, and Avid/Eli Lilly.. Dr. Borrie has received research support from Biogen, Merck, Eisai, Eli Lilly, Abbvie, Roche, Genentech, Novartis. Dr. Dowlatshahi has nothing to disclose. Dr. Finger has received personal compensation in an editorial capacity for NeuroImage:Clinical.Dr. Freedman has nothing to disclose. Dr. Kwan has nothing to disclose. Dr. Lang has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Consultant: AbbVie, Acorda, AFFiRis, Biogen, Janssen, Lilly, Lundbeck, Merck, Paladin, Roche, Seelos, Syneos, Sun Pharma, Theravance. Dr. Lang has received royalty, license fees, or contractual rights payments from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, Cambridge University Press.Dr. Marras has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Grey Matter Technologies LLC, Acorda Therapeutics, EMD Serono. Dr. Marras has received research support from Acorda Therapeutics.Dr. Masellis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Arkuda Therapeutics, Ionis Pharmaceuticals, and Alector Pharmaceuticals. Dr. Masellis has received research support from Roche, Novartis, Alector Pharmaceuticals.Dr. Shoesmith has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Mitsubishi Tanabe Pharma Canada. Dr. Swartz has nothing to disclose. Dr. Tan has nothing to disclose. Dr. Tartaglia has nothing to disclose. Dr. Zinman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Mitsubishi Tanabe Pharma Canada.Dr. Investigators has nothing to disclose. Dr. Munoz has nothing to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.147
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.267
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2020
Admission routes2
Has abstractyes

Explore more

Same venueNeurologySame topicGaze Tracking and Assistive TechnologyFrench-language works237,207